These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22236579)

  • 1. Human tetraspanin transmembrane 4 superfamily member 4 or intestinal and liver tetraspan membrane protein is overexpressed in hepatocellular carcinoma and accelerates tumor cell growth.
    Li Y; Wang L; Qiu J; Da L; Tiollais P; Li Z; Zhao M
    Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):224-32. PubMed ID: 22236579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated delivery of siRNA targeting TM4SF4 attenuated liver cancer cell growth in vitro and in vivo.
    Wang L; Feng J; Da L; Li Y; Li Z; Zhao M
    Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):213-9. PubMed ID: 23296076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
    Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.
    Liu LX; Jiang HC; Liu ZH; Zhu AL; Zhang WH; Wu LF; Zhou J; Wang XQ; Wu M
    Oncol Rep; 2003; 10(6):1771-5. PubMed ID: 14534694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma.
    Zhang CZ; Cao Y; Yun JP; Chen GG; Lai PB
    Histopathology; 2012 Jun; 60(7):1114-24. PubMed ID: 22372401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
    Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
    Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
    Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expressions of hepsin in human hepatocellular carcinomas.
    Chen CH; Su KY; Tao MH; Lin SW; Su YH; Tsai YC; Cheng KC; Jeng YM; Sheu JC
    Liver Int; 2006 Sep; 26(7):774-80. PubMed ID: 16911458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of decreased nidogen-2 expression in the tumor tissue and serum of patients with hepatocellular carcinoma.
    Cheng ZX; Huang XH; Wang Q; Chen JS; Zhang LJ; Chen XL
    J Surg Oncol; 2012 Jan; 105(1):71-80. PubMed ID: 21815147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
    Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target.
    Ito H; Funahashi S; Yamauchi N; Shibahara J; Midorikawa Y; Kawai S; Kinoshita Y; Watanabe A; Hippo Y; Ohtomo T; Iwanari H; Nakajima A; Makuuchi M; Fukayama M; Hirata Y; Hamakubo T; Kodama T; Tsuchiya M; Aburatani H
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3257-64. PubMed ID: 16740745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
    Heringlake S; Hofdmann M; Fiebeler A; Manns MP; Schmiegel W; Tannapfel A
    J Hepatol; 2010 Feb; 52(2):220-7. PubMed ID: 20036025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
    Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
    Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the gene for transmembrane 4 superfamily member 4 accelerates liver damage in rats treated with CCl4.
    Qiu J; Liu Z; Da L; Li Y; Xuan H; Lin Q; Li F; Wang Y; Li Z; Zhao M
    J Hepatol; 2007 Feb; 46(2):266-75. PubMed ID: 17069928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
    Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
    Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.